REX Bionics PLC, Auckland, New Zealand, developer of the Rex robotic exoskeleton, has been awarded a grant by Callaghan Innovation, a body of the New Zealand government that promotes innovation. The company anticipates the total contribution toward the cost of its REX 3 program during the three-year funding period could be more than 1.5 million New Zealand dollars (about US $1.27 million, as of August 11).